900181851	900181851	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
05179465	05179465	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8043426	8043426	CD	B-NP	O
|	|	CC	I-NP	O
4/18/2006	4/18/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
PNA	PNA	NN	B-NP	B-protein
,	,	,	O	O
viral	viral	JJ	B-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2006	9/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
12/10/2006	12/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MICHALES	MICHALES	NNP	B-NP	O
,	,	,	O	O
DAREN	DAREN	NNP	B-NP	O
M	M	NNP	I-NP	O
522-03-89-2	522-03-89-2	CD	I-NP	O
Dego	Dego	NNP	I-NP	O
Louisbi	Louisbi	NNP	I-NP	O
Do	Do	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/12/06	8/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	B-protein
UPON	UPON	NN	I-NP	I-protein
2PM	2PM	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
WILL	WILL	NN	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JOELSON	JOELSON	NNP	B-NP	O
,	,	,	O	O
EFREN	EFREN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
defib	defib	NN	I-NP	O
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
intubation	intubation	NN	I-NP	O
/	/	SYM	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/17/06	3/17/06	CD	B-NP	O
by	by	IN	B-PP	O
LINEA	LINEA	NNP	B-NP	O
,	,	,	O	O
ALLEN	ALLEN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
806913847	806913847	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/17/06	3/17/06	CD	B-NP	O
by	by	IN	B-PP	O
CORKRON	CORKRON	NNP	B-NP	O
,	,	,	O	O
FERDINAND	FERDINAND	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TESSALON	TESSALON	NN	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
Cough	Cough	NNP	B-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
GUIATUSS	GUIATUSS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
Cough	Cough	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
As	As	IN	B-ADJP	O
per	per	IN	B-PP	O
MH	MH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
LEVOXYL	LEVOXYL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/17/06	3/17/06	CD	B-NP	O
by	by	IN	B-PP	O
PIZZULO	PIZZULO	NN	B-NP	B-protein
,	,	,	O	O
CARLOS	CARLOS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
806913847	806913847	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOPERAMIDE	LOPERAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Diarrhea	Diarrhea	NNP	I-NP	O
ATIVAN	ATIVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LORAZEPAM	LORAZEPAM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
METOLAZONE	METOLAZONE	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
Weight	Weight	NNP	B-NP	O
gain	gain	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRAVACHOL	PRAVACHOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PRAVASTATIN	PRAVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

reports	report	NNS	B-NP	O
problems	problem	NNS	I-NP	O
with	with	IN	B-PP	O
simvastatin	simvastatin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

please	please	VB	B-VP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
substitute	substitute	VB	I-VP	O
.	.	.	O	O

thank	thank	VB	B-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/06	6/1/06	CD	B-NP	O
by	by	IN	B-PP	O
VOEDISCH	VOEDISCH	NNP	B-NP	O
,	,	,	O	O
MYLES	MYLES	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/06	6/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BOYES	BOYES	NNP	B-NP	O
,	,	,	O	O
GERARDO	GERARDO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
928583734	928583734	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/17/06	3/17/06	CD	B-NP	O
by	by	IN	B-PP	O
STEWART	STEWART	NNP	B-NP	O
,	,	,	O	O
BRENDON	BRENDON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
516577286	516577286	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/25/06	10/25/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Loparo	Loparo	NNP	I-NP	O
9/21/06	9/21/06	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/9/06	6/9/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Jerald	Jerald	NNP	B-NP	O
Delguidice	Delguidice	NNP	I-NP	O
via	via	IN	B-PP	O
VNA	VNA	NNP	B-NP	O
report	report	NN	I-NP	O
to	to	TO	B-PP	O
Jordge	Jordge	NNP	B-NP	O
Tine	Tine	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
PNA	PNA	NN	B-NP	B-protein
,	,	,	O	O
viral	viral	JJ	B-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
lung	lung	NN	I-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
endometrial	endometrial	JJ	I-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
endometrial	endometrial	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
ca	ca	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
flash	flash	NN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CXR	CXR	NNP	I-NP	O
,	,	,	O	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
,	,	,	O	O
R/O	R/O	NNP	B-NP	O
MI	MI	NNP	I-NP	O
,	,	,	O	O
Abdo	Abdo	NNP	B-NP	O
CT	CT	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NNP	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Watterson	Watterson	NNP	I-NP	O
,	,	,	O	O
75M	75M	NNP	B-NP	O
****	****	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
****	****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75F	75F	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CHF/CAD	CHF/CAD	NN	I-NP	O
,	,	,	O	O
A-fib	A-fib	NN	B-NP	B-protein
,	,	,	O	O
lung	lung	NN	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
5-6	5-6	CD	B-NP	O
times	time	NNS	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
6	6	CD	I-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
a	a	DT	B-NP	O
6lb	6lb	NN	I-NP	B-protein
weight	weight	NN	I-NP	I-protein
gain	gain	NN	I-NP	I-protein
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
experienced	experience	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
required	require	VBD	B-VP	O
more	more	JJR	B-NP	O
pillows	pillow	NNS	I-NP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
uses	use	VBZ	B-VP	O
2	2	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
SOB/orthopnea	SOB/orthopnea	NNP	I-NP	O
worsened	worsen	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
when	when	WRB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
fall	fall	VB	I-VP	O
asleep	asleep	RB	B-ADVP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
almost	almost	RB	B-ADVP	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Per	Per	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
's	's	POS	B-NP	O
instructions	instruction	NNS	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
took	take	VBD	B-VP	O
Metolazone	Metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
Torsamide	Torsamide	NN	I-NP	B-protein
40mg	40mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
UOP	UOP	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
ROS	ROS	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
+	+	SYM	B-NP	O
PND	PND	NN	I-NP	O
+	+	SYM	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
+	+	SYM	B-NP	O
fever	fever	NN	I-NP	O
+	+	SYM	B-NP	O
chills	chill	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
chronic	chronic	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
+	+	SYM	B-NP	O
decreased	decrease	VBD	B-VP	O
UOP	UOP	NN	B-NP	B-protein
x	x	SYM	O	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
L	L	NN	B-NP	O
leg	leg	NN	I-NP	O
swelling	swell	VBG	B-VP	O
for	for	IN	B-PP	O
weeks	week	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
no	no	DT	B-NP	O
N/V/D	N/V/D	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
pyuria	pyuria	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Vitals	Vital	NNS	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
T98	T98	NN	B-NP	O
.6	.6	CD	I-NP	O
P72	P72	NN	I-NP	O
BP121/65	BP121/65	NN	I-NP	O
RR18	RR18	NN	I-NP	O
SaO2	SaO2	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
:	:	:	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
Pt	Pt	NN	I-NP	O
recieved	recieve	VBD	B-VP	O
O2	O2	NN	B-NP	O
and	and	CC	O	O
40	40	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
IV	IV	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
Rx	Rx	NN	I-NP	B-protein
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ASA	ASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Acetylsalicylic	Acetylsalicylic	NNP	I-NP	O
Acid	Acid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
325MG	325MG	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	NN	B-NP	O
PO	PO	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Docusate	Docusate	NNP	B-NP	O
Sodium	Sodium	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Colace	Colace	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Esomeprazole	Esomeprazole	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
Nexium	Nexium	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Ferrous	Ferrous	NNP	B-NP	O
Sulfate	Sulfate	NNP	I-NP	O
PO	PO	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Kcl	Kcl	NNP	B-NP	O
Slow	Slow	NNP	I-NP	O
Release	Release	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Slow	Slow	NNP	I-NP	O
Rel	Rel	NNP	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

20	20	CD	B-NP	O
MEQ	MEQ	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Levoxyl	Levoxyl	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Levothyroxine	Levothyroxine	NNP	I-NP	O
Sodium	Sodium	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Lorazepam	Lorazepam	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ativan	Ativan	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
prn	prn	NN	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
,	,	,	O	O
Anxiety	Anxiety	NNP	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
PO	PO	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NNP	B-NP	O
Succinate	Succinate	NNP	I-NP	O
Extended	Extended	NNP	I-NP	O
Release	Release	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Toprol	Toprol	NNP	I-NP	O
Xl	Xl	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Multivitamins	Multivitamins	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ocuvite	Ocuvite	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
BID	BID	NNP	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Pravastatin	Pravastatin	NN	B-NP	O
PO	PO	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Torsemide	Torsemide	NNP	B-NP	O
PO	PO	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
BID	BID	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Warfarin	Warfarin	NNP	B-NP	O
Sodium	Sodium	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
****	****	SYM	B-NP	I-protein
Allergies	Allergy	NNPS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
****	****	SYM	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
a-fib	a-fib	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
lung	lung	NN	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
cell	cell	NN	I-NP	O
CA	CA	NN	I-NP	O
on	on	IN	B-PP	O
lip	lip	NN	B-NP	O
s/p	s/p	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
uterine	uterine	JJ	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH	TAH	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
FHx	FHx	NN	I-NP	O
:	:	:	O	O
non	non	JJ	B-NP	O
contrib	contrib	NN	I-NP	O
****	****	SYM	O	O
Social	Social	NNP	B-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
with	with	IN	B-PP	O
husband	husband	NN	B-NP	O
across	across	IN	B-PP	O
street	street	NN	B-NP	O
from	from	IN	B-PP	O
CCH	CCH	NN	B-NP	B-protein
.	.	.	O	O

+	+	SYM	O	O
tob	tob	NN	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
-	-	HYPH	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
,	,	,	O	O
-	-	HYPH	B-NP	O
IVDU	IVDU	NN	I-NP	O
****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
97.6	97.6	CD	B-NP	O
P77	P77	NN	I-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
NR	NR	NN	B-NP	O
RR20	RR20	NN	I-NP	O
SaO2100	SaO2100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
C/V	C/V	NN	I-NP	O
irreg	irreg	NN	I-NP	O
irreg	irreg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	B-protein
crackles	crackle	NNS	I-NP	I-protein
at	at	IN	B-PP	I-protein
L	L	NN	B-NP	I-protein
base	base	NN	I-NP	I-protein
,	,	,	O	O
faint	faint	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
R	R	NN	B-NP	B-protein
base	base	NN	I-NP	I-protein
.	.	.	O	O

Legs	Leg	NNS	B-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
but	but	CC	O	O
equal	equal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
redness	redness	NN	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	B-protein
shin	shin	NN	I-NP	I-protein
+	+	SYM	B-NP	O
faint	faint	NN	I-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
Small	Small	JJ	B-NP	O
L	L	NN	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
mild	mild	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
A-fib	A-fib	NN	B-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-NP	O
****	****	SYM	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
75F	75F	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
CAD/CHF/lung	CAD/CHF/lung	NN	I-NP	I-protein
CA/Afib	CA/Afib	NN	I-NP	I-protein
with	with	IN	B-PP	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
borderline	borderline	JJ	B-NP	O
elevated	elevated	JJ	I-NP	O
WBC	WBC	NNP	I-NP	O
and	and	CC	O	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
C/V	C/V	NN	I-NP	B-protein
+	+	SYM	B-NP	I-protein
I	I	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
R/OMI	R/OMI	NN	B-NP	B-protein
`	`	``	O	O
ed	ed	VBN	B-VP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
sets	set	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
for	for	IN	B-PP	O
causes	cause	NNS	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
rx	rx	NN	I-NP	O
of	of	IN	B-PP	O
betablocker	betablocker	NN	B-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	B-protein
+	+	SYM	B-NP	I-protein
P	P	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
Pt	Pt	NN	I-NP	O
normotensive	normotensive	JJ	B-ADJP	O
.	.	.	O	O

Likely	Likely	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
given	give	VBN	I-VP	O
CXR	CXR	NN	B-NP	B-protein
,	,	,	O	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
HPI	HPI	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Metolazone	Metolazone	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
60mg	60mg	NN	B-NP	O
of	of	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
5mg	5mg	NN	B-NP	O
of	of	IN	B-PP	O
Metolazone	Metolazone	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
120mg	120mg	NN	B-NP	O
of	of	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
roughly	roughly	RB	B-NP	O
negative	negative	JJ	I-NP	O
1.3	1.3	CD	I-NP	O
L.	L.	NNP	I-NP	O
Pt	Pt	NNP	I-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
clinically	clinically	RB	B-ADVP	O
well	well	RB	I-ADVP	O
when	when	WRB	B-ADVP	O
on	on	IN	B-PP	O
4/23	4/23	CD	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
Cr	Cr	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
2.5	2.5	CD	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
Torsemide	Torsemide	NN	I-NP	O
and	and	CC	I-NP	O
Metolazone	Metolazone	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
even	even	RB	B-ADVP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/4	3/4	CD	B-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
72.9	72.9	CD	B-NP	O
kg	kg	NN	I-NP	O
from	from	IN	B-PP	O
70.6	70.6	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
rx	rx	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
20mg	20mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pm	pm	NN	I-NP	O
returning	return	VBG	B-VP	O
as	as	IN	B-SBAR	O
71.7	71.7	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
3/4	3/4	CD	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
158	158	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
or	or	CC	O	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
orthopnea/SOB	orthopnea/SOB	NN	I-NP	I-protein
.	.	.	O	O

+	+	SYM	B-NP	O
R	R	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
During	During	IN	B-PP	O
her	her	PRP	B-NP	O
stay	stay	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
afib	afib	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
bblocker	bblocker	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
supertheraputic	supertheraputic	JJ	B-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
3.9	3.9	CD	B-NP	O
to	to	TO	B-PP	O
4.0	4.0	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
1/2	1/2	CD	B-NP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
with	with	IN	B-PP	O
VNA/PCP	VNA/PCP	NN	B-NP	O
f/u	f/u	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
d/ced	d/ce	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
1mg	1mg	NN	I-NP	O
qpm	qpm	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ID	ID	NN	I-NP	B-protein
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
UA	UA	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
CTX	CTX	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
pt	pt	NN	I-NP	O
developed	develop	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
c.diff	c.diff	NN	B-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
recieved	recieve	VBD	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT.	CT.	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
colitis	colitis	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
a	a	DT	B-NP	O
LLL	LLL	NN	I-NP	B-protein
consolidation	consolidation	NN	I-NP	I-protein
likely	likely	RB	B-NP	I-protein
PNA	PNA	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
but	but	CC	B-PP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
o2	o2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
improve	improve	VB	I-VP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
because	because	IN	B-SBAR	O
pt	pt	NN	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
ceftaz	ceftaz	NN	B-NP	O
and	and	CC	I-NP	O
levo	levo	NN	I-NP	O
for	for	IN	B-PP	O
gram	gram	NN	B-NP	O
pos	po	NNS	I-NP	O
coverage	coverage	NN	I-NP	O
-LRB-	-LRB-	FW	B-NP	O
levo	levo	FW	I-NP	O
-RRB-	-RRB-	FW	I-NP	O
double	double	JJ	I-NP	O
gram	gram	NN	I-NP	O
neg	neg	NN	I-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
atypical	atypical	JJ	B-NP	B-protein
coverage	coverage	NN	I-NP	I-protein
-LRB-	-LRB-	FW	B-NP	I-protein
levo	levo	FW	I-NP	I-protein
-RRB-	-RRB-	FW	I-NP	I-protein
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
hospital	hospital	NN	I-NP	O
aquired	aquire	VBD	B-VP	O
PNA	PNA	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
multiple	multiple	JJ	I-NP	O
hosp	hosp	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
improved	improve	VBD	B-VP	O
clinically	clinically	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
d/ced	d/ce	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
q48h	q48h	NN	I-NP	O
x	x	SYM	B-NP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
ceftaz	ceftaz	NN	I-NP	O
changed	change	VBD	B-VP	O
to	to	TO	I-VP	O
cefpodoxime	cefpodoxime	VB	I-VP	O
200mg	200mg	CD	B-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
c.diff	c.diff	NN	B-NP	O
given	give	VBN	I-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
whitecount	whitecount	NN	I-NP	O
.	.	.	O	O

however	however	RB	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
only	only	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Cdiff	Cdiff	NN	B-NP	O
,	,	,	O	O
fecal	fecal	JJ	B-NP	O
leuks	leuk	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
all	all	DT	B-NP	O
stool	stool	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Presumed	Presume	VBN	B-NP	O
viral	viral	JJ	I-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
loperamide	loperamide	NN	B-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
prn	prn	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Endocrine	Endocrine	JJ	I-NP	O
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
's	's	POS	B-NP	O
po	po	NN	I-NP	O
DM	DM	NN	I-NP	O
rx	rx	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
-	-	HYPH	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
Lantus	Lantus	NN	B-NP	O
and	and	CC	I-NP	O
Insulin	Insulin	NN	I-NP	B-protein
Asp	Asp	NN	I-NP	O
SS	SS	NN	I-NP	O
.	.	.	O	O

HgA1c	HgA1c	NN	B-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
nl	nl	NN	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
po	po	NN	I-NP	O
rx	rx	NN	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
levoxyl	levoxyl	NN	B-NP	O
;	;	:	O	O
TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
and	and	CC	O	O
within	within	IN	B-PP	O
nl	nl	NN	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
rx	rx	NN	I-NP	O
Allopurinol	Allopurinol	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
D/C	D/C	NN	B-NP	O
C/V	C/V	NN	I-NP	O
irreg	irreg	NN	I-NP	O
irreg	irreg	NN	I-NP	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
CTA	CTA	NN	I-NP	B-protein
with	with	IN	B-PP	O
faint	faint	JJ	B-NP	O
bibasalar	bibasalar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Trace	Trace	NN	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
****	****	SYM	O	O
Code	Code	NNP	B-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
resume	resume	VB	B-VP	O
your	your	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
:	:	:	O	O
Levofloxacin	Levofloxacin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
Cefpodoxime	Cefpodoxime	NNP	B-NP	O
200mg	200mg	CD	I-NP	O
by	by	IN	B-PP	O
moouth	moouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
**	**	SYM	B-NP	O
The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
:	:	:	O	O
Tessalon	Tessalon	NN	B-NP	O
Perels	Perel	VBZ	B-VP	O
100mg	100mg	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
Guiatuss	Guiatuss	NNP	B-NP	O
10ml	10ml	CD	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
Loperamide	Loperamide	NN	I-NP	O
2mg	2mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
**	**	SYM	B-NP	O
The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
:	:	:	O	O
Were	Were	NNP	B-NP	O
taking	take	VBG	B-VP	O
2mg	2mg	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
take	take	VBP	B-VP	O
1mg	1mg	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pm	pm	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
Please	Please	NN	I-NP	B-protein
have	have	VBP	B-VP	O
your	your	PRP$	B-NP	O
VNA	VNA	NN	I-NP	B-protein
draw	draw	VB	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	B-PP	O
Antsaint	Antsaint	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP/go	PCP/go	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
pillows	pillow	NNS	I-NP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptom	symptom	NN	I-NP	O
that	that	WDT	B-NP	O
concerns	concern	VBZ	B-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
RX	RX	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
recurrent	recurrent	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
supertheraputic	supertheraputic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
but	but	CC	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
coags	coag	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BARRIS	BARRIS	NNP	B-NP	O
,	,	,	O	O
WM	WM	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AH24	AH24	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/25/06	10/25/06	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

